BioCentury This Week

BioCentury This Week

BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs.

For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.

00:00
00:00

Folgen

393-

Ep. 383 - Moderna, Genentech obesity deal, Trump's FDA pick

24 Aug. 2026
392-

Ep. 382 - Summer’s venture wave; drugging beta-catenin; Capricor & FDA

17 Aug. 2026
391-

Ep. 381 - FIH urgency in the U.S. Plus: federated learning, biotech IPOs

10 Aug. 2026
390-

Ep. 380 - AZ-BMS rumors, Replimune, psychedelics

03 Aug. 2026
389-

Ep. 379 - Argenx M&A, AI giants and biopharma, catalyst scorecard

27 Jul. 2026